![](/img/cover-not-exists.png)
The pharmacokinetic and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction
Laeis, Petra, Püchler, Kurt, Kirch, WilhelmVolume:
19
Journal:
Journal of Hypertension
DOI:
10.1097/00004872-200106001-00004
Date:
June, 2001
File:
PDF, 49.47 MB
2001